Life Science News

- Johnson & Johnson (NYSE: JNJ) will participate in the Raymond James 43rd Annual Institutional Investors Conference on Tuesday, March 8 th .  Joseph J. Wolk, Executive Vice President and Chief Financial Officer, will represent the Company in a session scheduled at 1:05 p.m. (Eastern Time) .

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .

A webcast replay will be available approximately 48-hrs after the live webcast.

(PRNewsfoto/Johnson & Johnson)

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-the-raymond-james-43rd-annual-institutional-investors-conference-301479192.html

SOURCE Johnson & Johnson

News Provided by PR Newswire via QuoteMedia

JNJ
Sarama Resources Ltd

West African Gold Explorer & Developer, Sarama Resources, Lists on ASX, Raises A$8M

Sarama Resources Ltd. (“Sarama” or the “Company”) (ASX:SRR, TSXV:SWA) is pleased to announce that the Company’s securities have commenced trading on the Australian Securities Exchange (“ASX”) under the ASX code SRR following a strongly supported public offering which saw A$8M raised predominantly from a broad base of domestic and international institutional and sophisticated investors.